With Europe’s COVID-19 vaccine rollout lagging amid J&J and AZ holdups, CureVac readies mRNA doses for deployment nhigginsdunn Thu, 04/15/2021 – 15:38 More: With Europe’s COVID-19 vaccine rollout lagging amid J&J and AZ holdups, CureVac readies mRNA doses for deployment
read moreModerna eyes beefed-up vaccine production with the help of U.S.-brokered manufacturing talks: report fkansteiner Thu, 04/15/2021 – 10:52 More: Moderna eyes beefed-up vaccine production with the help of U.S.-brokered manufacturing talks: report Source: fierce
read moreActivist investor Elliott takes ‘significant’ stake in GlaxoSmithKline amid string of setbacks: report arlene.weintraub Thu, 04/15/2021 – 10:35 More: Activist investor Elliott takes ‘significant’ stake in GlaxoSmithKline amid string of setbacks: report Source: fierce
read moreSafety concerns with J&J’s COVID-19 vaccine present a big opportunity for Pfizer, Moderna: analyst kdunleavy Thu, 04/15/2021 – 09:38 More: Safety concerns with J&J's COVID-19 vaccine present a big opportunity for Pfizer, Moderna: analyst Source: fierce
read moreAlexion’s pricey Ultomiris wins backing from England’s cost watchdogs thanks to confidential discount aliu Thu, 04/15/2021 – 09:34 More: Alexion's pricey Ultomiris wins backing from England's cost watchdogs thanks to confidential discount Source: fierce
read moreThe funding will be used to advance Alchemab’s novel platform to identify disease-modifying antibody therapeutics More: Alchemab completes £60m Series A funding to advance novel antibody platform Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals